Search Result "SEN12333."
The Recent Development of α7 Nicotinic Acetylcholine Receptor (nAChR) Ligands as Therapeutic Candidates for the Treatment of Central Nervous System (CNS) Diseases
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 14 Year: 2016 Page: 2134-2151
Author(s): Corinne Beinat,Samuel D. Banister,Marco Herrera,Michael Kassiou
Editorial (Thematic Issue: Effective and Promising Treatments for Neurological Disorders and Cancer)
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 14 Year: 2016 Page: 1979-1980
Author(s): Victor V. Uteshev
Cognitive Improvement by Activation of α7 Nicotinic Acetylcholine Receptors: From Animal Models to Human Pathophysiology
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 323-343
Author(s): Morten S. Thomsen, Henrik H. Hansen, Mikkelsen B. Timmerman, Jens D. Mikkelsen
Novel Approaches to Study the Involvement of α7-nAChR in Human Diseases
Journal: Current Drug Targets
Volume: 13 Issue: 5 Year: 2012 Page: 579-586
Author(s): Eleonora Palma,Luca Conti,Cristina Roseti,Cristina Limatola
Neuronal Nicotinic Acetylcholine Receptors - Targets for the Development of Drugs to Treat Cognitive Impairment Associated with Schizophrenia and Alzheimers Disease
Journal: Current Topics in Medicinal Chemistry
Volume: 10 Issue: 2 Year: 2010 Page: 144-152
Author(s): Simon N. Haydar, John Dunlop
α7-Nicotinic Receptors and Cognition
Journal: Current Drug Targets
Volume: 13 Issue: 5 Year: 2012 Page: 602-606
Author(s): Edward D. Levin
Alpha7 Neuronal Nicotinic Receptors as Targets for Novel Therapies to Treat Multiple Domains of Schizophrenia
Journal: Current Pharmaceutical Biotechnology
Volume: 12 Issue: 3 Year: 2011 Page: 437-448
Author(s): Aaron J. Kucinski, Michal K. Stachowiak, Scott R. Wersinger, Patrick M. Lippiello, Merouane Bencherif